AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

FENNEC PHARMACEUTICALS INC. Director's Dealing 2017

Sep 20, 2017

35599_dirs_2017-09-20_5bfc827c-2095-48cc-9b6f-ea82c3eaf7c9.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11

Reporting Person: Raykov Rosty (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	40740	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.43	2018-08-18	Common Shares (323961)		Direct
Stock Option (right to buy)	$1.89	2018-08-18	Common Shares (17050)		Direct
Stock Option (right to buy)	$1.05	2019-11-20	Common Shares (50000)		Direct
Stock Option (right to buy)	$0.72	2020-08-20	Common Shares (16.666)		Direct
Stock Option (right to buy)	$1.59	2021-01-24	Common Shares (83333)		Direct
Stock Option (right to buy)	$2.69	2021-12-31	Common Shares (25000)		Direct
Stock Option (right to buy)	$2.45	2023-07-05	Common Shares (150000)		Direct
Stock Option (right to buy)	$5.10	2024-06-27	Common Shares (100000)		Direct

Footnotes

F1: Item is in Canadian dollars.